EP 1732599 A1 20061220 - USE OF EMMPRIN ANTAGONISTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH EXCESSIVE ANGIOGENESIS
Title (en)
USE OF EMMPRIN ANTAGONISTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH EXCESSIVE ANGIOGENESIS
Title (de)
VERWENDUNG VON EMMPRIN-ANTAGONISTEN ZUR BEHANDLUNG VON ERKRANKUNGEN IM ZUSAMMENHANG MIT ÜBERMÄSSIGER ANGIOGENESE
Title (fr)
UTILISATION D'ANTAGONISTES DE L'INDUCTEUR DE METALLOPROTEINASE DANS LA MATRICE EXTRACELLULAIRE POUR LE TRAITEMENT DE MALADIES ASSOCIEES A UN ANGIOGENESE EXCESSIVE
Publication
Application
Priority
US 2004009151 W 20040325
Abstract (en)
[origin: WO2005092381A1] A method of using EMMPRIN antagonists to treat pathological processes associated with proliferative diseases, such as cancer, by specifically preventing or inhibiting the ability of new tissue to develop a blood supply. The invention more specifically relates to methods of treating such diseases by the use of EMMPRIN antagonists such as antibodies directed toward EMMPRIN, including specified portions or variants, specific for at least one EMMPRIN protein or fragment thereof, in an amount effective to inhibit angiogenesis.
IPC 8 full level
A61K 39/395 (2006.01); A61P 35/00 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP)
A61K 39/39558 (2013.01); A61P 3/10 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 9/14 (2017.12); A61P 17/00 (2017.12); A61P 17/02 (2017.12); A61P 17/06 (2017.12); A61P 17/08 (2017.12); A61P 17/10 (2017.12); A61P 17/12 (2017.12); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 27/02 (2017.12); A61P 27/06 (2017.12); A61P 29/00 (2017.12); A61P 31/12 (2017.12); A61P 35/00 (2017.12); A61P 35/04 (2017.12); A61P 43/00 (2017.12); C07K 14/70503 (2013.01); C07K 16/2803 (2013.01); C07K 16/2896 (2013.01); A61K 2039/505 (2013.01); C07K 2317/76 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
LT LV
DOCDB simple family (publication)
WO 2005092381 A1 20051006; AU 2004317548 A1 20051006; CA 2560903 A1 20051006; CN 1960753 A 20070509; EP 1732599 A1 20061220; EP 1732599 A4 20080514; JP 2007530538 A 20071101
DOCDB simple family (application)
US 2004009151 W 20040325; AU 2004317548 A 20040325; CA 2560903 A 20040325; CN 200480043088 A 20040325; EP 04821758 A 20040325; JP 2007504930 A 20040325